1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Sacubitril + valsartan
Trade Name:
Entresto
Manufacturer/Distributor:
Novartis Pharmaceuticals Canada
Classification:
Endopeptidase inhibitor, angiotension II receptor antagonist
ATC Class:
C09DX04 - valsartan and sacubitril
Status:
active
Notice of Compliance (yyyy/mm/dd):
2015/10/02
Date Marketed in Canada (yyyy/mm/dd):
2015/11/13
Presentation:
Tablet: 24 mg sacubitril + 26 mg valsartan. DIN: 02446928
Tablet: 49 mg sacubitril + 51 mg valsartan. DIN: 02446936
Tablet: 97 mg sacubitril + 103 mg valsartan. DIN: 02446944
Comments:
For the treatment of heart failure with reduced ejection fraction (HFrEF) in patients with NYHA Class II or III, to reduce the incidence of cardiovascular death and heart failure hospitalisation.
Back to:
Drug Product Listings 
